Stockscreener 앱 받기
0.00
0.00%
0.00
Vitro Biopharma, Inc. 주식(VTRO)의 최신 뉴스
Cue Biopharma to present new in vitro data for CUE-401 - TipRanks
Cue Biopharma unveils in vitro data for CUE-401 in autoimmune disease research - Traders Union
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 - The Manila Times
CUE-401 lab data hint at rebalancing immune attacks in autoimmune disease - Stock Titan
The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant
Vitro Biopharma, Inc. Reports Earnings Results for the Full Year Ended October 31, 2025 - marketscreener.com
Best Biotech Stocks of 2026 and How to Invest in Them - The Motley Fool
Reviewing Rein Therapeutics (NASDAQ:RNTX) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World
Financial Contrast: Imunon (NASDAQ:IMNN) vs. Vitro Diagnostics (OTCMKTS:VODG) - Defense World
What Stem Cell Clinics Do You Trust? - BioInformant
10 cultured meat companies driving sustainable food in 2025 - Labiotech.eu
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat COVID-19 - ACCESS Newswire
The 16th international oncolytic virotherapy conference: from in vitro to clinical studies, novel approaches in cancer therapy meeting report - Frontiers
Dealmaking Quarterly Statistics, Q4 2024 - Citeline News & Insights
Stem Cell Therapy for the Coronavirus COVID-19 Pandemic - ACCESS Newswire
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
Closing the women’s health gap: Biopharma’s untapped opportunity - McKinsey & Company
Layoffs Continued Across Biopharma in 2024 - BioSpace
In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace
Swiss biotech going strong in 2024: 18 companies to put on your radar - Labiotech.eu
Top 5 In-Vitro Diagnostics [IVD] Companies - Fortune Business Insights
A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - BioSpace
FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data - ScienceDirect.com
EDGAR Filing Documents for 0001493152-24-004779 - SEC.gov
Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma
SIRION Biotech - Pharmaceutical Technology
Vitro Biopharma, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Kirk Cousins travels to Caribbean for stem cell treatment - kare11.com
Tickers - Finansavisen
In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research - Yahoo Finance
IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha
Vitro Biopharma, Inc. announced a financing transaction - marketscreener.com
Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire
Vitro Biopharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
The Next Normal – The future of biotech: AI-driven drug discovery - McKinsey & Company
GT Biopharma Poster Presentation and Mini Oral Session at - GlobeNewswire
Vitro Biopharma Names Chris Furman Chief Executive Officer - Yahoo Finance
Biotech - McKinsey & Company
Business of Biotechniques 2022 - BioTechniques
Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine - Stock Titan
Developing A Robust In Vitro Intestinal Model For Preclinical Candidate Screening Of GI Toxicity - Pharmaceutical Online
User - FinancialContent
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19 - BioInformant
DVC Stem: Stem Cell Therapy Clinic in the Cayman Islands - BioInformant
In vitro glycoengineeringSuitability for BioPharma manufacturing - Labroots
Critically Ill COVID-19 Patient Successfully Treated with Vitro Biopharma’s AlloRx Stem Cells(R) - BioInformant
Vor Biopharma Raises $110M to Develop Engineered Hematopoietic Stem Cells - BioInformant
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - ACCESS Newswire
VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30 th 2019 financial results of operations. - SEC.gov
Fujifilm Acquiring Irvine Scientific, IS Japan for $800M, with Cell Culture Media Growth in Mind - Genetic Engineering and Biotechnology News
Global Stem Cell Technologies and Applications Market 2018-2018Visiongain Report - PR Newswire UK
Here Are the Top 10 In Vitro Diagnostic Companies - BioSpace
Human Organs-on-Chips - Wyss Institute at Harvard
Merck KGaA debuts new fertility tech division - BioPharma Dive
Vitro Diagnostics (VODG) Stock Price, News & Analysis - MarketBeat
Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours - News-Medical
VODG Logo - Cision News
1.20%
0.06%
자본화:
|
볼륨(24시간):